Dr. Hönle AG

euro adhoc: Dr. Hönle AG
Financial Figures/Balance Sheet
Hönle continues to improve revenue and earnings

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

15.12.2008

According to preliminary figures, the Hönle Group (SIC 515710) saw a significant increase in both revenues and earnings in financial year 2007/2008 with sales revenues rising by 85.7 % to TEUR 48,744 in comparison with the previous year´s period. Earnings before interest and tax (EBIT) improved 29.7 % to TEUR 5,627 while earnings before tax (EBT) grew by 18.9 % to TEUR 5,904. Consolidated net income for the year rose by 44.0 % and amounted to TEUR 4,561.

Hönle acquired three companies in the last financial year. In January 2008 Hönle acquired the Panacol Group. PrintConcept GmbH, a UV specialist for UV dryers in the graphic segment was purchased in the same month followed by the purchase of Eltosch GmbH, an established supplier of drying systems for the printing industry, in May. Cash and cash equivalents, financial assets and own shares declined from TEUR 20,320 to TEUR 11,702 due to the corporate acquisitions in the last financial year. Liabilities to banks amount to EUR 1 million, the investment volume used for the expansion of business activities will probably be under one million euro. The capital ratio comes to 62.9 %.

Outlook: The Hönle Group succeeded in raising its market share significantly as a result of the corporate acquisitions. At the same time the Company laid the foundations for sustained powerful growth of the corporate group. In the new financial year special emphasis will be placed on the speedy integration of the acquired companies, the strengthening of existing synergies with respect to sales, development and production as well as the realisation of cost savings potential. The production of Eltosch GmbH has been outsourced to external companies to date. In the future, drying equipment of the Eltosch brand will be manufactured at Dr. Hönle AG in addition to Hönle products, and this will increase efficiency in the production of UV and IR systems. At the same time a high quality standard of the plants is ensured for the printing industry. Moreover, it is planned to extend existing customer relationships and gain new customers through direct access in the sheet-fed offset segment. Panacol GmbH and Wellomer GmbH will move to new corporate premises. The resulting synergy effects will lead to another long-term increase in the Hönle Group´s operating result. A further revenue increase is expected to result from the extension of sales in the South-East Asian region, in particular. The major integration measures will probably be finalised by the end of the financial year.

The economic slowdown and current investment restraints will impact on the business development of the Hönle Group also. The extent and duration of the restrained investor behaviour, in particular in the printing industry, is difficult to predict at present. Overall, Hönle expects an increase in revenues in comparison with the previous year as a consequence of the initial full consolidation of the acquisitions. Operating results will be below the previous year´s level.

Hönle is responding to the changing economic conditions by introducing short-time work at Dr. Hönle AG and Eltosch GmbH. Against this background, the Dr. Hönle AG Management Board and Supervisory Board will propose to the Annual General Meting that a dividend of EUR 0.25 per share (PY: EUR 0.40 per share) of the unappropriated retained earnings of Dr. Hönle AG be distributed.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Dr. Hönle AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Peter Weinert
Tel.: +49 (0)89 856 08 173
E-Mail: peter.weinert@hoenle.de

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Hamburg / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: